MINIMAL RESIDUAL DISEASE IN PERIPHERAL BLOOD ASSESSED BY MASS SPECTROMETRY
Main Author: | Noemi Puig |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000829508.72678.01 |
Similar Items
-
MASS SPECTROMETRY AS A TOOL FOR MINIMAL RESIDUAL DISEASE DETECTION IN THE BLOOD OF MYELOMA PATIENTS
by: J.F.M. Jacobs
Published: (2023-05-01) -
Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry
by: Somayya Noori, et al.
Published: (2023-02-01) -
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future
by: Alejandro Medina-Herrera, et al.
Published: (2023-07-01) -
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms
by: Paula Aguirre-Ruiz, et al.
Published: (2020-11-01) -
Mass spectrometry--from peripheral proteins to membrane motors.
by: Morgner, N, et al.
Published: (2012)